100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothTacrolimus 0.25mg
You Searched
Tacstead 0.25mg Capsule
Steadfast Medishield Pvt. Ltd.
₹140
Our Recommendation
Tacrenolime 0.25mg Capsule 10s
2,136+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Prevention of organ rejection in transplant patients
Customers also bought
More About Tacstead
Benefits
In Prevention of organ rejection in transplant patients : Tacstead 0.25mg Capsule belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.
Side Effects
Side effects of Tacstead Capsule The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Tacstead Increased glucose level in blood Kidney damage Insomnia (difficulty in sleeping)Tremors High blood pressure Infection
How to use
How to use Tacstead Capsule Follow your doctor's guidance regarding the dose and duration of this medication. Tacstead 0.25mg Capsule is to be taken empty stomach.
How it works
How Tacstead Capsule works Tacstead 0.25mg Capsule is an immunosuppressant. It works by suppressing your body�s immune response following the transplant of an organ (e.g., liver, kidney, heart). This helps your body to accept the new organ as if it were your own.
Unsafe: Avoid consuming alcohol with Tacstead 0.25mg Capsule as it is deemed unsafe.
Tacstead 0.25mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Tacstead 0.25mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Tacstead 0.25mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Tacstead 0.25mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Tacstead 0.25mg Capsule may be needed. Doctor consultation is advised.
Tacstead 0.25mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Tacstead 0.25mg Capsule may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Tacstead 0.25mg Capsule is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Steadfast MediShield Pvt. Ltd, Plot # 330, Functional Industrial Estate, Patparganj, Delhi - 110 092
References
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309
Tacrolimus monohydrate. Camberley, Surrey: Sandoz Limited; 2010 (23 Jan. 2019)
Tacrolimus. Princeton, New Jersey: Sandoz Inc; 2009 (06 Apr. 2019)
Central Drugs Standard Control Organisation. Tacrolimus (06 Aug. 2023)
Tacrolimus (06 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
